| Patent Number |
Title Of Patent |
Date Issued |
| PP18221 |
Cactaceae plant named `Elsie` |
November 20, 2007 |
| A variety of the Cactaceae family produced in a controlled hybridization `Elise`. The variety possesses the desirable characteristics of: a strong growth habit with erect stems; a red colored bloom; relatively large flowers; a strong propensity to branch with minimal pruning; and flowers |
| PP18177 |
Cactaceae plant named `Harmony` |
November 6, 2007 |
| A plant variety of the Cactaceae family, Schlumbergera truncata, called `Harmony` having a deep colored bloom characterized as R.H.S. 46 B (red group). The new variety has a strong resistance to bud abscission, a strong propensity for buds to mature and flower, an erect growth habit, |
| PP16678 |
Boltonia plant named `Masbolimket` |
June 20, 2006 |
| A new and distinct cultivar of Boltonia plant named `Masbolimket` characterized by its single inflorescence form, violet-colored ray florets, yellow-colored disc florets, dark green-colored foliage, freely branching character, and medium upright growth habit. |
| PP15378 |
Cactaceae plant named `Rio` |
November 30, 2004 |
| A variety of the Cactaceae family produced by a controlled cross named `Rio`. `Rio` has a strong growth habit, a "red" colored bloom, a strong propensity to branch with minimal pruning, erect stems, and blooming flowers that last for two weeks on the plant. |
| PP11327 |
Cactaceae plant named `Avalon` |
April 4, 2000 |
| A new and distinct plant variety of the Cactaceae family arising as a spontaneous mutation of Hatiora.times.graeseri `Evita`, is distinguishable from its progenitor and related varieties by its larger flowers, larger pollen grains, larger and thicker phylloclades, reduced branching, and |
| 7616303 |
Systems and methods for correcting optical reflectance measurements |
November 10, 2009 |
| We disclose measurement systems and methods for measuring analytes in target regions of samples that also include features overlying the target regions. The systems include: (a) a light source; (b) a detection system; (c) a set of at least first, second, and third light ports which trans |
| 7602985 |
Multi-scale enveloping spectrogram signal processing for condition monitoring and the like |
October 13, 2009 |
| A signal processing technique that decomposes complex, dynamically changing non-stationary signals from machine components such as bearings into different scales by means of a continuous wavelet transform. The envelope signal in each scale is then calculated from the modulus of the w |
| 7598313 |
Amphiphilic polymer capsules and related methods of interfacial assembly |
October 6, 2009 |
| Polymer capsules from amphiphilic graft copolymers comprising reactive, hydrophobic polyolefin backbones, and hydrophilic poly(ethylene glycol) (PEG) grafts are produced by self-assembly of the polymers at the oil-water interface, and crosslinking the assembly with bis-cyclooctene PE |
| 7597676 |
Malleolar pad |
October 6, 2009 |
| The malleolar pad of preferred embodiments of the present invention provides a treating physician with the ability to monitor pressure at a wound site, adjust the pressure to more accurately treat and facilitate healing of, for example, a pressure ulcer while providing adequate wound |
| 7589240 |
Quantum dots tailored with electronically-active polymers |
September 15, 2009 |
| Cadmium selenide, and other quantum dot materials, can be integrated into thin films of poly(para-phenylene vinylene) (PPV) or other polymer compounds without aggregation of the nanocrystals. Solid-state photoluminescence spectra of composite materials prepared by these novel techniq |
| 7582741 |
Conditional disruption of dicer1 in cell lines and non-human mammals |
September 1, 2009 |
| The present invention is based, at least in part, on the generation of cells, cell lines and non-human mammals that contain a synthetic conditional allele of the Dicer1 gene. Many of the constructs, methods, animals and cells of the invention feature recombinase recognition sites (in |
| 7575686 |
Process for autotrophic perchlorate reduction using elemental sulfur and mollusk shells |
August 18, 2009 |
| The invention relates to a system and method to reduce perchlorate in wastewater utilizing perchlorate-reducing bacteria, sulfur as an electron donor and mollusk shells as alkalinity agent. Embodiments of the invention include a perchlorate-reduction system comprising a bioreactor un |
| 7572669 |
Nanocylinder arrays |
August 11, 2009 |
| Pathways to rapid and reliable fabrication of nanocylinder arrays are provided. Simple methods are described for the production of well-ordered arrays of nanopores, nanowires, and other materials. This is accomplished by orienting copolymer films and removing a component from the film to |
| 7566548 |
Methods for identifying therapeutic agents and for treating disease |
July 28, 2009 |
| Included are methods of identifying compounds that mimic the interaction of Apoptin and APC1, e.g., binding of Apoptin to APC1, e.g., dissociation of APC1 from the APC/C, and compounds identified by the methods. Compounds that specifically mimic an interaction of Apoptin and APC1, e. |
| 7566531 |
Selective whole cell quartz crystal microbalance biosensors |
July 28, 2009 |
| Selective whole cell QCM biosensors are disclosed. Also disclosed are methods of making and using such whole cell QCM biosensors, e.g., to screen drugs and diagnose diseases. |
| 7566454 |
Influenza nucleic acids, polypeptides, and uses thereof |
July 28, 2009 |
| Codon-optimized nucleic acids encoding influenza polypeptides and uses of the nucleic acids and polypeptides for inducing immune responses are provided herein. |
| 7563848 |
Crosslinked polycyclooctene |
July 21, 2009 |
| Chemically crosslinked polycyclooctene having excellent shape recovery properties and a method for its synthesis via ring-opening metathesis polymerization of cyclooctene using the dihydroimidazolylidene-modified Grubbs catalyst are disclosed. The polycyclooctene products, following |
| 7563507 |
Pyridine and related ligand compounds, functionalized nanoparticulate composites and methods of |
July 21, 2009 |
| Nanoparticulate composites and dispersion thereof using novel polymeric ligand compounds, in certain embodiments in conjunction with pyridinyl moieties coupling the nanoparticulate and ligand. |
| 7560233 |
Oxidative DNA damage protection |
July 14, 2009 |
| Provided herein are methods of screening compounds, gene sequences, and gene products in bacteria for agents that are protective against oxidative DNA damage in a human or animal. Gene sequences identified by these screens can also be used in diagnostic assays that identify subjects |
| 7560227 |
Biomarkers of vulnerable atherosclerotic plaques and methods of use |
July 14, 2009 |
| The present invention provides compositions suitable for use as biomarkers of vulnerable plaques as well as methods for the use of such compositions. In preferred embodiments, specific molecular imaging agents are provided that permit the selective identification of vulnerable plaque |
| 7556835 |
High efficiency protein extraction |
July 7, 2009 |
| The invention relates to a process for isolating edible protein from animal muscle by solubilizing the protein in an alkaline aqueous solution. |
| 7553674 |
Methods of identifying compounds useful for modulating intraflagellar transport |
June 30, 2009 |
| The invention relates to various intraflagellar transport (IFT) polypeptides and the nucleic acids that encode them. The new IFT particle polypeptides and nucleic acids can be used in a variety of diagnostic, screening, and therapeutic methods. |
| 7550136 |
Photo-reactive polymers and devices for use in hair treatments |
June 23, 2009 |
| The invention provides new methods to treat hair to achieve a permanent wave, curl, or straightness. |
| 7544714 |
Lipid-amino acid conjugates and methods of use |
June 9, 2009 |
| N-fatty acid-amino acid conjugates and J.sub.2 prostanoid-amino acid conjugates are disclosed along with methods for making such conjugates and methods of using these conjugates in the treatment of conditions that involve dysfunctional lipid metabolism, insulin sensitivity, glucose h |
| 7541161 |
Method and apparatus for preparing cells for microtome sectioning and archiving nucleic acids an |
June 2, 2009 |
| A method and apparatus for embedding cells that utilizes a flow-through embedding technique maximizes the efficiency of extractions and decreases time for embedding the cell fragments, minimizes cell loss, and automatically positions cell samples at the position in which a microtome |
| 7532919 |
Measuring tissue oxygenation |
May 12, 2009 |
| Methods and systems for calculating tissue oxygenation, e.g., oxygen saturation, in a target tissue are disclosed. In some embodiments, the methods include: (a) directing incident radiation to a target tissue and determining reflectance spectra of the target tissue by measuring inten |
| 7531183 |
Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
May 12, 2009 |
| An isolated, biologically active 33 kDa Hemagglutinin purified from the type A Clostridium botulinum neurotoxin complex and its uses are described. |
| 7527826 |
Adhesion of a metal layer to a substrate by utilizing an organic acid material |
May 5, 2009 |
| Methods and resulting structures are described in which a metal layer is adhered to a surface of a substrate. The methods involve applying a sacrificial acidic organic layer to the surface of the substrate prior to depositing the metal layer onto the substrate. During deposition of the |
| 7508966 |
Optical fourier systems and methods for medical image processing |
March 24, 2009 |
| A preferred embodiment optical system for processing a medical image includes an input image, a light source emitting a light beam which is directed at the input image, a first Fourier optical transformer receiving and focusing the light beam, and at least one spatial filter disposed |
| 7507547 |
Screening assays for antioxidants and antiproliferative compounds |
March 24, 2009 |
| Provided are screening assays for identifying and evaluating compounds with antioxidant and/or antiproliferative activities. |
| 7507527 |
Detection of human immunodeficiency virus |
March 24, 2009 |
| The invention relates to a method of detecting a HIV-infected cell in a mammal. The method includes detecting an HIV 2-LTR circle DNA molecule obtained from a cell of an HIV-positive mammal, especially an HIV-1-positive human. |
| 7507504 |
Optical storage system |
March 24, 2009 |
| The present invention includes an optical system to control and optimize molecular reorientation for information storage. A preferred embodiment of the invention utilizes light sources emitting at wavelengths centered on or around the absorption bands of the storage medium. The light can |
| 7504216 |
Bacterial counterselectable hybrid systems |
March 17, 2009 |
| The present application relates to the hybrid selection methods in prokaryotes using counterselectable reporter genes. |
| 7501124 |
Methods of inducing T-cell non-responsiveness with anti-gp39 24-31 antibodies |
March 10, 2009 |
| Methods for inducing T cell tolerance to a tissue or organ graft in a transplant recipeint are disclosed. The methods involve administering to a subject: 1) an allogeneic or xenogeneic cell which expresses donor antigens and which has a ligand on the cell surface which interacts with |
| 7498316 |
Methods and compositions for treating gain-of-function disorders using RNA interference |
March 3, 2009 |
| The present invention relates to novel methods for treating dominant gain-of-function diseases. The invention provides methods for targeting regions of the copper zinc superoxide dismutase (SOD1), which causes inherited amyotrophic lateral sclerosis (ALS), with RNAi agent. The invent |
| 7498155 |
Microbial nanowires, related systems and methods of fabrication |
March 3, 2009 |
| Conductive nanowires, as are available from a range of bacteria species, methods of use and related device structures. |
| 7482174 |
Disease markers for early stage atherosclerosis |
January 27, 2009 |
| The invention relates to methods of diagnosing early stages of atherosclerosis. |
| 7473797 |
Methods of 1,3-enyne preparation using copper (I) catalysts |
January 6, 2009 |
| A copper(I) bi-dentate ligand complex-catalyzed procedure for synthesis of 1,3-enynes. The methods and/or systems of this invention afford a variety of enynes, tolerate a variety of sensitive functional groups, and can be employed without resort to expensive palladium reagents. |
| 7473786 |
Methods and systems for preparing fused heterocyclic compounds using copper(I) catalysts |
January 6, 2009 |
| A copper(I)-catalyzed procedure for the synthesis of benzo[b]heterocycles. This protocol can be used to synthesize a variety of 2-arylbenzo[b]furans and indoles in good to excellent yields. This method can tolerate a variety of functional groups, does not require the use of expensive |
| 7472359 |
Behavioral transformations for hardware synthesis and code optimization based on Taylor Expansio |
December 30, 2008 |
| A systematic method and system for behavioral transformations for hardware synthesis and code optimization in software compilation based on Taylor Expansion Diagrams. The system can be integrated with any suitable architectural synthesis system. It can also be built into a compiler tool |
| 7470840 |
Liquid-liquid interfacial nanoparticle assemblies |
December 30, 2008 |
| Self-assembly of nanoparticles at the interface between two fluids, and methods to control such self-assembly process, e.g., the surface density of particles assembling at the interface; to utilize the assembled nanoparticles and their ligands in fabrication of capsules, where the el |
| 7469857 |
System and method for altitude control |
December 30, 2008 |
| An differential expansion system and method for balloon buoyancy control which includes a zero-pressure envelope and a superpressure envelope. A gas transfer device is positioned between the envelopes to facilitate the transfer of lift gases that are lighter than air between the envelope |
| 7468269 |
Reagents for recombinogenic engineering and uses thereof |
December 23, 2008 |
| The present invention features homologous recombination methods and systems. The methods and systems promote highly efficient homologous recombination in cells (e.g., in prokaryotic cells). The methods and systems are useful, for example, in pharmaceutical drug development, vaccine d |
| 7460514 |
Adaptive media control |
December 2, 2008 |
| A media control approach that supports transmission of data streams with QoS requirements, such as minimum throughput or maximum delay, while adapting to the changing characteristics of the transmission medium. The media control approach includes use of a polling manager and a resource |
| 7459547 |
Methods and compositions for controlling efficacy of RNA silencing |
December 2, 2008 |
| Based at least in part on an understanding of the mechanisms by which small RNAs (e.g., naturally-occurring miRNAs) mediate RNA silencing in plants, rules have been established for determining, for example, the degree of complementarity required between an RNAi-mediating agent and it |
| 7455985 |
Detection and quantification of intracellular pathogens |
November 25, 2008 |
| The present invention provides methods and compositions for detecting bacteria of the Chlamydiaceae family in a biological sample. Methods include, for example, contacting a biological sample with an antibody that specifically binds to a chlamydial antigen displayed on the surface of |
| 7431935 |
Proteins within the type E botulinum neurotoxin complex |
October 7, 2008 |
| The invention features a polypeptide complex synthesized by bacteria of the genus Clostridia that contains the serotype E botulinum neurotoxin and five neurotoxin associated polypeptides having molecular weights of about 118, 80, 65, 40, and 18 kDa. respectively. The complex is useful in |
| 7428241 |
Energy/bandwidth efficient medium access control protocol for wireless packet networks |
September 23, 2008 |
| An improved medium access protocol is divided into two tasks: collision avoidance and contention resolution. The purpose of the collision avoidance is to avoid occasional collisions due to the synchronization of channel access among different stations. The purpose of contention resol |
| 7423018 |
Kinesin-like proteins and methods of use |
September 9, 2008 |
| The invention relates to methods and compounds for treating subjects who have proliferative disorders. The invention also relates to screening methods for identifying such compounds. The methods and compositions target the activity of the human kinesin-like protein KIF18A (and the KI |
| 7419834 |
System for detection of nitrosylated proteins |
September 2, 2008 |
| The present invention describes a novel, simplified method for detecting and monitoring whether the presence of nitrosylated proteins, such as S-nitrosoproteins, in a biological sample using fluorescence detection. The present invention further describes a method which can both quantify |
